Researcher Accused of Insider Trading Has Worked for Many Drugmakers

November 8, 2010
The clinical researcher facing 25 years in prison for unlawfully tipping off a hedge fund manager about negative trial results is listed as an investigator for at least one ongoing clinical trial by Novo Nordisk. French national Yves Benhamou is listed as a principal investigator for a diabetes trial with Novo Nordisk, according to ClinicalTrials.gov. Company spokeswoman Lori Moore declined to comment. Benhamou has consulted for other companies, including Abbott, Novartis, Roche and Vertex, according to disclosure statements from several medical journals.
Washington Drug Letter